PharmTech
CONTINUE TO SITE >

OR WAIT 15 SECS

From Genome Exploration to Drug Development

June 2, 2003
Jill Wechsler
Jill Wechsler

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Pharmaceutical Technology, Pharmaceutical Technology-06-02-2003, Volume 27, Issue 6

FDA's plan to establish pharmacogenomic policies spurs concerns among manufacturers, particularly in regard to how the policies will affect new-drug testing and approval.